Novus Therapeutics, Inc. (NASDAQ: NVUS) Reports 4th Quarter and Full-Year 2k18 Financial Results and Provides Clinical Updates - NyseNewsRoom

Novus Therapeutics, Inc. (NASDAQ: NVUS) Reports 4th Quarter and Full-Year 2k18 Financial Results and Provides Clinical Updates  NyseNewsRoom

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, ...



Comments

Popular posts from this blog

Summary of Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and management of fetal growth restriction - Contemporary Obgyn

Sarcoidosis: Causes, Symptoms, Diagnosis & Treatment